New daily pill shows promise for weight loss in phase 2 trial

NCT ID NCT06828055

Completed Disease control Sponsor: Viking Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental daily pill, VK2735, to help adults with obesity or overweight (plus a weight-related health issue) lose weight. About 280 participants took either the pill or a placebo for 13 weeks. The main goal was to see how much weight they lost and if the pill was safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WEIGHT LOSS

Contacts and locations

Locations

Viking Clinical Site #100

Indianapolis, Indiana, 46260, United States
Viking Clinical Site #101

Clearwater, Florida, 33756, United States
Viking Clinical Site #102

Port Orange, Florida, 32127, United States
Viking Clinical Site #103

Knoxville, Tennessee, 37909, United States
Viking Clinical Site #104

Austin, Texas, 78705, United States
Viking Clinical Site #105

Lake Forest, California, 96230, United States
Viking Clinical Site #106

San Antonio, Texas, 78229, United States
Viking Clinical Site #107

Ocoee, Florida, 34761, United States
Viking Clinical Site #108

Largo, Florida, 33777, United States
Viking Clinical Site #109

City of Saint Peters, Missouri, 63303, United States
Viking Clinical Site #110

Louisville, Kentucky, 40213, United States
Viking Clinical Site #111

Peoria, Arizona, 85381, United States
Viking Clinical Site #112

Kansas City, Missouri, 64131, United States
Viking Clinical Site #113

Butte, Montana, 59701, United States
Viking Clinical Site #114

Marrero, Louisiana, 70072, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.